Dose distribution along the transverse axis of a new 125I source for interstitial brachytherapy

被引:18
作者
Nath, R [1 ]
Yue, N [1 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
关键词
I-125; source; interstitial brachytherapy; dose-rate constant;
D O I
10.1118/1.1319520
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
A new encapsulated source of I-125 has been introduced far interstitial brachytherapy. This source, isoSTAR(TM) model 12501 (manufactured by Imagyn Corp.), consists of a welded titanium tube containing I-125 as silver iodide uniformly coated on five silver beads. The dose rate constant and the radial dose function for this source were measured using lithium fluoride thermoluminescent dosimeters in a Solid Water(R) phantom. The value of the dose rate constant is 0.95 cGy h(-1) U-1 where the unit of air kerma strength is 1 U = 1 cGy h(-1) cm(2). The air kerma strength was traceable to the year 2000 primary air kerma strength standard far the model 12501 source at the National Institute of Technology and Standards. The radial dose function for the source was very similar to that for the model 6711 source (manufactured by Nycomed Amersham) for radial distances up to 6 cm. However, the radial dose function is lower in value than that for the model 6702 source (manufactured by Nycomed Amersham) and the model MED3631-A/M IogoId source (manufactured by North American Scientific). (C) 2000 American Association of Physicists in Medicine. [S0094-2405(00)01611-4].
引用
收藏
页码:2536 / 2540
页数:5
相关论文
共 26 条
[1]
Biochemical disease-free survival following I-125 prostate implantation [J].
Beyer, DC ;
Priestley, JB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03) :559-563
[2]
Blasko, 1993, Semin Radiat Oncol, V3, P240, DOI 10.1016/S1053-4296(05)80121-3
[3]
Blasko JC, 1998, PROSTATE CANCER, P137
[4]
PROSTATE-SPECIFIC ANTIGEN BASED DISEASE-CONTROL FOLLOWING ULTRASOUND-GUIDED (125)IODINE IMPLANTATION FOR STAGE T1/T2 PROSTATIC-CARCINOMA [J].
BLASKO, JC ;
WALLNER, K ;
GRIMM, PD ;
RAGDE, H .
JOURNAL OF UROLOGY, 1995, 154 (03) :1096-1099
[5]
Pd-103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma [J].
Dattoli, M ;
Wallner, K ;
Sorace, R ;
Koval, J ;
Cash, J ;
Acosta, R ;
Brown, C ;
Etheridge, J ;
Binder, M ;
Brunelle, R ;
Kirwan, N ;
Sanchez, S ;
Stein, D ;
Wasserman, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05) :875-879
[6]
Dosimetric characteristics of a new 125I brachytherapy source [J].
Gearheart, DM ;
Drogin, A ;
Sowards, K ;
Meigooni, AS ;
Ibbott, GS .
MEDICAL PHYSICS, 2000, 27 (10) :2278-2285
[7]
Limitations of the point and line source approximations for the determination of geometry factors around brachytherapy sources [J].
Karaiskos, P ;
Sakelliou, L ;
Sandilos, P ;
Vlachas, L .
MEDICAL PHYSICS, 2000, 27 (01) :124-128
[8]
DETAILED PRELIMINARY-ANALYSIS OF I-125 IMPLANTATION FOR LOCALIZED PROSTATE-CANCER USING PERCUTANEOUS APPROACH [J].
KAYE, KW ;
OLSON, DJ ;
PAYNE, JT .
JOURNAL OF UROLOGY, 1995, 153 (03) :1020-1025
[9]
EXPOSURE STANDARDIZATION OF I125 SEEDS USED FOR BRACHYTHERAPY [J].
LOFTUS, TP .
JOURNAL OF RESEARCH OF THE NATIONAL BUREAU OF STANDARDS, 1984, 89 (04) :295-303
[10]
COMPARISON OF RADIATION-DOSIMETRY IN WATER AND IN SOLID PHANTOM MATERIALS FOR I-125 AND PD-103 BRACHYTHERAPY SOURCES - EGS4 MONTE-CARLO STUDY [J].
LUXTON, G .
MEDICAL PHYSICS, 1994, 21 (05) :631-641